![Ram Aiyar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ram Aiyar
Directeur Général chez
Korro Bio, Inc.
Fortune : 920 001 $ au 31/08/2026
Profil
Ram Aiyar was the founder of Corvidia Therapeutics, Inc., founded in 2015, where the title held was CFO, Executive VP & Head-Business Development in 2020.
Dr. Aiyar is also the founder of Protean Bio, Inc...
Current jobs include President, Chief Executive Officer & Director at Korro Bio, Inc. (United States) since 2020; President, CEO, CFO & Director at Korro Bio, Inc. starting 2025; Director at Triveni Bio, Inc.; and Advisor at Atlas Venture Advisors, Inc. Former jobs include Director at Avidea Technologies, Inc.; Chief Commercial Officer at FlowMetric LLC from 2012 to 2013; and Associate at Sofinnova Partners SAS from 2011 to 2012.
Education includes graduate and doctorate degrees from Drexel University, an MBA from INSEAD, and an undergraduate degree from the University of Mumbai conferred in 1999.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,5% | 04/08/2026 | 73 659 ( 0,5% ) | 920 001 $ | 31/08/2026 |
Postes actifs de Ram Aiyar
| Sociétés | Poste | Début |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Directeur Général | 10/11/2020 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Ram Aiyar
| Sociétés | Poste | Fin |
|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Fondateur | 01/11/2020 |
FlowMetric LLC
 FlowMetric LLC Medical/Nursing ServicesHealth Services Provides pre-clinical, toxicology & safety, clinical and cell sorting services | Corporate Officer/Principal | 01/05/2013 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Analyste en capital-investissement | 01/10/2012 |
Avidea Technologies, Inc.
 Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Directeur/Membre du Conseil | - |
Formation de Ram Aiyar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
FlowMetric LLC
FlowMetric LLC Medical/Nursing ServicesHealth Services Provides pre-clinical, toxicology & safety, clinical and cell sorting services | Health Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
Avidea Technologies, Inc.
Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Commercial Services |
